ロード中...
EphA2 chimeric antigen receptor-modified T cells for the immunotherapy of esophageal squamous cell carcinoma
BACKGROUND: It is urgent to explore an effective potential therapeutic strategy for ESCC. In recent years, cell-based cancer immunotherapy has become a potentially close for carcinoma therapy. Chimeric antigen receptor (CAR) T cell technology is a kind of adoptive cell therapy technique which has be...
保存先:
| 出版年: | J Thorac Dis |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
AME Publishing Company
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6006048/ https://ncbi.nlm.nih.gov/pubmed/29997940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jtd.2018.04.91 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|